Föreskrifter om ändring i Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika

1 1 Senast ändrade genom HSLF-FS 2019:16.

HSLF-FS 2019:18

– – – – – – – – – – – –

Anmärkning

– – – – – – – – – – – – – – – – – –

tionell I – IV P I P – – – – – – – – – – – – – – – – – – förteckning – – –

Interna

ing – – – – – – – – – – – – II I– I– V– IV

Svensk förteckn

– – – – – – – – – – – – – – – – – –

– – – – – – – – – – – – – – – – – –

– – – – – – – – – – – – – – –

-oxazolin beteckning – – – – – – – – – – – – – – – – – –

Specifik kemisk

1H-inden-2-amin I

– – – – – – – – – – – – – – – – – –

7-[(10,11-dihydro-5H- dibenso[a,d]cyklohepten-5- yl)amino]heptansyra 2,3-dihydro- 2-amino-5-fenyl-2 2-amino-1-(4-bromo-2,5- dimetoxifenyl)etanon 1-(1,3-bensodioxol-5-yl)-2- (bensylamino)propan-1-on – – – – – – – – – – – – – – –

n

– – – – – – – – – – – – – – – – – –

ndra vanligt A

– – – – – – – – – – – – – – – – – –

förekommande nam

2-aminoindan bk-2C-B BMDP

– – – – – – – – – – – – – – –

tin – – – – – – ep orex – – – – – – – – – – – –

INN-benämning

2 Ämne – – – Amin Amin – – – Brallobarbital – – –

HSLF-FS 2019:18

– – – – – – – – – – – –

– – – – – – – – – – – – – – – – – –

I I – P IV P II – – – – – – – – – – – – – – – – – – – – –

– – – – – – – – – – – – I– IN I IN I IV

– – – – – – – – – – – – – – – – – –

– – – – – – – – – – – – 4- – – – – – – -( din-4- ]-N

peri 4-yl – – – – – – – – – – – – – – – nyl)pi idi per enylet fenyl)-1,3-dihydro-2H-1,4- n – – – – – – – – – – – – )pi – – – – – – loro -(2-fenyletyl)piperidin-4- etyl 1-(2-f epin-2-o enyl -f – – – – – – – – – – – – (2 – – – – – – ro-5-(o-k 1- -[ N-fenyl-N-[ yl]cyklopentankarboxamid N-fenyl-N-[1 yl]cyklopropankarboxamid 7-klo bensodiaz 1-(4-fluorofenyl)propan-2-amin N fluorofenyl)butanamid N-etyl-1-(3-fluorofenyl)propan-2-amin – – – – – – – – – – – – – – –

– – – – – – – – – – – – – – – – – –

– – – – – – – – – – – – – – – – – – Cyklopentylfentanyl Cyklopropylfentanyl 4-fluoroamfetamin 4-fluoramfetamin 4-FA 4-fluorobutyrfentanyl 4F-BF Para- fluorobutyrylfentanyl 3-fluoroetamfetamin 3-FEA

– – – – – – – – – – – – – – –

– – – – – – – – – – – – – – – – – –

– – – Delorazepam – – – – – – 3

HSLF-FS 2019:18

– – – – – – – – – – – –

– – – – – – – – – – – – – – – – – –

I I I I I – P – – – – – – – – – – – – – – – – – – – – –

– – – – – – – – – – – – I IN IN I IN I–

– – – – – – – – – – – – – – – – – –

on xan – – – – – – 2- – – – – – – he 4- – – – – – – -( -( ]-N yklo ]-N l)c – – – – – 4-yl – – – – – 4-yl – – – – – n- nidi din-4- xifeny idi per per piperi – – – – – – )pi – – – – – – )pi – – – – – – yl) -(3-meto -fenyletyl)piperidin-4-yl]-2etyl etyl o)-2 enyl fenylet enyl -f -f – – – – – – (2 – – – – – – (2 – – – – – – 1- 1- [1-(2- -[ -[ 2-(3-fluorofenyl)-3-metylmorfolin N fluorofenyl)propanamid N- yl]-N-(4-fluorofenyl)-2-metylpropanamid 2-(etylamin N-fenyl-N-[1-(2 metoxiacetamid N metoxifenyl)butanamid – – – – – – – – – – – – – – –

– – – – – – – – – – – – – – – – – –

– – – – – – – – – – – – – – – – – – 3-fluorofenmetrazin 3-FPM 2-fluorofentanyl Orto-fluorofentanyl 4-fluoroisobutyrfentanyl 4F-iBF Metoxetamin MXE Metoxiacetylfentanyl 4-metoxibutyrfentanyl 4-MeO-BF

– – – – – – – – – – – – – – –

– – – – – – – – – – – – – – – – – –

4 – – – – – – – – –

HSLF-FS 2019:18

– – – – – – – – – – – –

– – – – – – – – – – – – – – – – – –

I IV + N I – – – – – – – – – – – – – – – – – – – – –

– – – – – – – – – – – – I– I– I– II I– IN

– – – – – – – – – – – – – – – – – –

– – – – – – n- – – – – – – – – – – – – idi

pyrrol – – – – – – – – – – – – – – – )-2-(

fenyl – – – – – – – – – – – – – – – – – – etyl m rgolin-8-karboxamid 1-(4- – – – – – – – – – – – – – – – – – – etyl- luoro-N-(1-fenetyl-4- 1-(3-metoxifenyl)-2-(metylamino)propan- 1-on 1-yl)pentan-1-on 1-[4-(3-fenylprop-2-en-1-yl)-2- metylpiperazin-1-yl]butan-1-on N,N-dietyl-6-metyl-1-propanoyl-9,10- didehydroe piperidyl)propionanilid – – – – – – – – – – – – – – –

P 4-m iH anyl 4’-f – – – – – – P – – – – – – – – – – – – nt alfayl- luorfe – – – – – – – – – – – – – – – – – – 3-metoximetkatinon 4-met 2-metyl-AP-237 1P-LSD Para-f

– – – – – – – – – – – – – – –

n 14-hydroxidihydrokodeinon – – – – – – – – – – – – – – – – – –

– – – – – – Oxykodo – – – 5

HSLF-FS

2019:18 Dessa föreskrifter träder i kraft den 6 augusti 2019. Läkemedelsverket NILS GUNNAR BILLINGER Joakim Brandberg

HSLF-FS kan laddas ner via Läkemedelsverket. Webb: www.lakemedelsverket.se

Författningen kan beställas via: Norstedts Juridik 106 47 Stockholm Telefon: 08-598 191 90 SVANENMÄRKET E-post: kundservice@nj.se Internet: www.nj.se/offentligapublikationer 3041 0123Trycksak

Elanders Sverige AB, 2019